谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Pilot trial of priming with oral TAK-228 and TAK-117 (PIKTOR) to increase DNA damage repair deficiency (DDRD) followed by cisplatin (cis) and nab paclitaxel (nab pac) in chemotherapy-pretreated metastatic triple negative breast cancer (metTNBC) pts

Joyce O'Shaughnessy,Esther San Roman Rodriguez,Priscilla Ontiveros,Rick Wenstrup,Tiziano Pramparo,Jessica Lang,Victoria Zismann,Natalia Briones,William Hendricks,Virginia Espina,Claudius Mueller,Maren K. Levin

CANCER RESEARCH（2021）

引用 0|浏览11
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要